21 Centrale Partners to acquire controlling interest in DL Software, French leader in ERP solutions for SMEs

May 19, 2017

21 Centrale Partners announces the acquisition of DL Software (Alternext Paris listed company) alongside Amundi PEF and Swen Capital Partners, as minority shareholders, within the scope of a transaction initiated in February 2017. This transaction will be the first investment of the fifth generation of French funds for the management company.

21 Centrale Partners acquired the majority of the capital and voting rights of DL Invest and Phoenix, both of which directly and indirectly hold approximately 84.33% of the capital of DL Software. The founding Managers also invest for a minority stake in the capital.

DL Software provides a range of ERP platforms and complementary modules to more than 9,000 clients, in 4 sectors and 8 subsectors, targeting niche markets: biomedical laboratories, dentist centers, opticians, mutual health insurances, materials wholesale, beverages wholesale, sport retail and tourism. In 2016, DL Software reached sales of approximately 50 million euros.

Stephane Perriquet and Fabrice Voituron, respectively Managing Partner and Partner of 21 Centrale Partners comment: "With its software solutions, DL Software has a considerable potential for development and is armed to take market shares in each of the businesses in which it operates. 21 will support the group in pursuing its active external growth strategy and will bring all its know-how in this field."

Jean-Noël Drouin and Patrick Lemaire, Founders of DL Software highlight: "The realization of this operation constitutes a solid opportunity for the company. 21 Centrale Partners is not only a recognized player in the French private equity market, our choice is above all driven by a common vision and an enduring development project combining internal growth through innovation and dynamic external growth."

ProductLife Group expands to India and Central Europe

After having acquired French-based AxPharma and US-based DS InPharmatics, PLG continues its dynamic development with this new build-up. It allows the group, acquired by 21 Invest France in 2019, to establish itself in India and strengthen its position in Central Europe, thus enhancing its value proposition with offshoring capacities.
Read more
Load More
Fail to load posts. Try to refresh page.